Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heme arginate crossover study in metabolic syndrome
NL-OMON29539Recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Aug 2010
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Randomised trial of heme arginate and arginine in cardiometabolic risk (CMR) (2 arms), sponsored by Radboud University Medical Center. Primary endpoint: Insulin sensitivity. Started Aug 2010; status: recruiting.
02
Drugs
heme arginatearginine
03
Conditions
cardiometabolic risk (CMR)
Beyond the preview
Go deeper on NL-OMON29539.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON29539.